Limited duration of vaccine poliovirus and other enterovirus excretion among human immunodeficiency virus infected children in Kenya

BMC Infectious Diseases

Volumn 9, Issue , 2009, Pages 136-

  Khetsuriani, Nino ^a   Helfand, Rita ^a   Pallansch, Mark ^a   Kew, Olen ^a   Fowlkes, Ashley ^a   Oberste, M S ^a   Tukei, Peter ^b   Muli, Joseph ^b   Makokha, Ernest ^b   Gary, Howard ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

POLIOMYELITIS VACCINE;

ARTICLE; CHILD; CONTROLLED STUDY; DEMOGRAPHY; ENTEROVIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES ANALYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; KENYA; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; ORPHANAGE; POLIOMYELITIS; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; VIRUS CULTURE; VIRUS EXCRETION; VIRUS ISOLATION; VIRUS LOAD; VIRUS SHEDDING; VIRUS TYPING; CLASSIFICATION; DISEASE TRANSMISSION; ENTEROVIRUS INFECTION; FECES; GENETICS; ISOLATION AND PURIFICATION; POLIOMYELITIS VIRUS; PRESCHOOL CHILD; VIROLOGY;

CHILD, PRESCHOOL; ENTEROVIRUS; ENTEROVIRUS INFECTIONS; FECES; HIV INFECTIONS; HUMANS; KENYA; POLIOMYELITIS; POLIOVIRUS; POLIOVIRUS VACCINES; VIRUS SHEDDING;

EID: 70349776718     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-9-136     Document Type: Article

References (37)

1. Wood DJ, Sutter RW, Dowdle WR. Stopping poliovirus vaccination after eradication: issues and challenges. Bull WHO 2000, 78:347-357. 2560716, 10812731.
2. Technical Consultative Group to the World Health Organization on the Global Eradication of Poliomyelitis "Endgame" issues for the global polio eradication initiative. Clin Infect Dis 2002, 34:72-77. 10.1086/338262, 11731948.
3. Centers for Disease Control and Prevention Public Health Dispatch: Poliomyelitis - Madagascar, 2002. MMWR Morb Mortal Wkly Rep 2002, 51:622.
4. Centers for Disease Control and Prevention Circulation of a type 2 vaccine-derived poliovirus - Egypt, 1982-1993. MMWR Morb Mortal Wkly Rep 2001, 50:41-42. 11215882.
5. Centers for Disease Control and Prevention Acute flaccid paralysis associated with circulating vaccine-derived poliovirus - Philippines, 2001. MMWR Morb Mortal Wkly Rep 2001, 50:874-875.
6. Kew O, Morris-Glasgow V, Landaverde M, Burns C, Shaw J, Garib Z, André J, Blackman E, Freeman CJ, Jorba J, Sutter R, Tambini G, Venczel L, Pedreira C, Laender F, Shimizu H, Yoneyama T, Miyamura T, Avoort H, Oberste MS, Kilpatrick D, Cochi S, Pallansch M, de Quadros C. Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus. Science 2002, 296:356-359. 10.1126/science.1068284, 11896235.
7. Kew OM, Sutter RW, Nottay BK, McDonough MJ, Prevots DR, Quick L, Pallansch MA. Prolonged replication of a type 1 vaccine-derived poliovirus in an immunodeficient patient. J Clin Microbiol 1998, 36:2893-2899. 105084, 9738040.
8. Khetsuriani N, Prevots DR, Quick L, Elder ME, Pallansch M, Kew O, Sutter RW. Persistence of vaccine-derived polioviruses among immunodeficient persons with vaccine-associated paralytic poliomyelitis. J Infect Dis 2003, 188:1845-1852. 10.1086/379791, 14673763.
9. Sutter RW, Prevots DR. Vaccine-associated paralytic poliomyelitis among immunodeficient persons. Infect Med 1994, 11:426.
10. Wilfert CM, Buckley R, Rosen FS. Persistent enterovirus infections in agammaglobulinemia. ASM symposium on persistent viral infections. Microbiology 1977, 488-493. ASM Press, Washington, DC, Schlessinger D.
11. Italian Pediatric/Intestinal HIV study Group Intestinal malabsorption of HIV-infected children: relationship to diarrhea, failure to thrive, enteric microorganism and immune impairment. AIDS 1993, 7:1435-1440.
12. Liste MB, Natera I, Suarez JA, Pujol FH, Liprandi F, Ludert JE. Enteric viral infections and diarrhea in healthy and human immunodeficiency virus-infected children. J Clin Microbiol 2000, 38:2873-2877. 87134, 10921942.
13. Tormey VJ, Buscombe JR, Johnson MA, Thomson AP, Webster AD. SPECT scans for monitoring response to pleconaril therapy in chronic enteroviral meningoencephalitis. J Infect 2003, 46:138-40. 10.1053/jinf.2002.1074, 12634077.
14. Chakraborty R, Iturriza-Gómara M, Musoke R, Palakudy T, D'Agostino A, Gray J. An epidemic of enterovirus 71 infection among HIV-1-infected orphans in Nairobi. AIDS 2004, 18:1968-70. 10.1097/00002030-200409240-00018, 15353988.
15. Gouandjika-Vasilache I, Akoua-Koffi C, Begaud E, Dosseh A. No evidence of prolonged enterovirus excretion in HIV-seropositive patients. Trop Med Int Health 2005, 10:743-7. 10.1111/j.1365-3156.2005.01454.x, 16045460.
16. Onorato IM, Markowitz LE. Immunization, vaccine-preventable diseases, and HIV infection. AIDS and other manifestations of HIV infection 1992, 671-681. New York: Raven Press, Woemser GP, 2.
17. Ryder RW, Oxtoby MJ, Mvula M, Battera V, Baende E, Nsaa W, Davachi F, Hassig S, Onorato I, Deforest A, Kashamuka M, Heyward WL. Safety and immunogenicity of bacille Calmette-Guerin, diphtheria-tetanus-pertussis, and oral polio vaccines in newborn children in Zaire infected with human immunodeficiency virus type 1. J Pediatr 1993, 122:697-702. 10.1016/S0022-3476(06)80007-7, 8496745.
18. Moss WJ, Clements CJ, Halsey NA. Immunization of children at risk of infection with human immunodeficiency virus. Bull WHO 2003, 81:61-70. 2572316, 12640478.
19. Robertson S. The Immunological basis for immunization series. Module 6: Poliomyelitis. 1993, 1-24. World Health Organization, Geneva.
20. Chitsike I, van Furth R. Paralytic poliomyelitis associated with live oral poliomyelitis vaccine in child with HIV infection in Zimbabwe: case report. BMJ 1999, 318:841-843. 27799, 10092261.
21. Ion Nedelcu N, Dobrescu A, Strebel PM, Sutter RW. Vaccine-associated paralytic poliomyelitis and HIV infection. Lancet 1994, 343:51-52. 10.1016/S0140-6736(94)90903-2, 7905058.
22. Centers for Disease Control and Prevention 1994 Revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR 1994, 43(RR-12):1-10.
23. Kilpatrick DR, Nottay B, Yang CF, Yang SJ, Da Silva E, Peñaranda S, Pallansch M, Kew O. Serotype-specific identification of polioviruses by PCR using primers containing mixed-base or deoxyinosine residues at positions of codon degeneracy. J Clin Microbiol 1998, 36:352-357. 104541, 9466740.
24. Avoort HG, Hull BP, Hovi T, Pallansch MA, Kew OM, Crainic R, Wood DJ, Mulders MN, van Loon AM. Comparative study of five methods for intratypic differentiation of polioviruses. J Clin Microbiol 1995, 33:2562-2566. 228529, 8567883.
25. Kilpatrick DR, Ching K, Iber J, Campagnoli R, Freeman CJ, Mishrik N, Liu HM, Pallansch MA, Kew OM. Multiplex PCR method for identifying recombinant vaccine-related polioviruses. J Clin Microbiol 2004, 42:4313-4315. 10.1128/JCM.42.9.4313-4315.2004, 516318, 15365031.
26. Liu HM, Zheng DP, Zhang LB, Oberste MS, Kew OM, Pallansch MA. Serial recombination during circulation of type 1 wild-vaccine recombinant polioviruses in China. J Virol 2003, 77:10994-11005. 10.1128/JVI.77.20.10994-11005.2003, 225006, 14512548.
27. Oberste MS, Nix WA, Maher K, Pallansch MA. Improved molecular identification of enteroviruses by RT-PCR and amplicon sequencing. J Clin Virol 2003, 26:375-7. 10.1016/S1386-6532(03)00004-0, 12637088.
28. Oberste MS, Maher K, Kilpatrick DR, Flemister MR, Brown BA, Pallansch MA. Typing of human enteroviruses by partial sequencing of VP1. J Clin Microbiol 1999, 37:1288-93. 84754, 10203472.
29. Hennessey KA, Lago H, Diomande F, Akoua-Koffi C, Caceres VM, Pallansch MA, Kew OM, Nolan M, Zuber PL. Poliovirus vaccine shedding among persons with HIV in Abidjan, Cote d'Ivoire. J Infect Dis 2005, 192:2124-8. 10.1086/498166, 16288377.
30. Asturias EJ, Grazioso CF, Luna-Fineman S, Torres O, Halsey NA. Poliovirus excretion in Guatemalan adults and children with HIV infection and children with cancer. Biologicals 2006, 34:109-12. 10.1016/j.biologicals.2006.03.002, 16682223.
31. Pavlov DN, Van Zyl WB, Kruger M, Blignaut L, Grabow WO, Ehlers MM. Poliovirus vaccine strains detected in stool specimens of immunodeficient children in South Africa. Diagn Microbiol Infect Dis 2006, 54:23-30. 10.1016/j.diagmicrobio.2005.08.011, 16290028.
32. Pavlov DN, Van Zyl WB, Van Heerden J, Kruger M, Blignaut L, Grabow WO, Ehlers MM. Prevalence of vaccine-derived polioviruses in stools of immunodeficient children in South Africa. J Appl Microbiol 2006, 101:1367-79. 10.1111/j.1365-2672.2006.03020.x, 17105568.
33. Alexander JP, Gary HE, Pallansch MA. Duration of poliovirus excretion and its implications for acute flaccid paralysis surveillance: a review of literature. J Infect Dis 1997, 175(suppl 1):S176-S182.
34. Más Lago P, Cáceres VM, Galindo MA, Gary HE, Valcarcel M, Barrios J, Sarmiento L, Avalos I, Bravo JA, Palomera R, Bello M, Sutter RW, Pallansch MA, de Quadros CA. Persistence of vaccine-derived poliovirus following a mass vaccination campaign in Cuba: implications for stopping polio vaccination alter global eradication. Int J Epidemiol 2001, 30:1029-1034. 10.1093/ije/30.5.1029, 11689516.
35. Kew OM, Wright PF, Agol VI, Delpeyroux F, Shimizu H, Nathanson N, Pallansch MA. Circulating vaccine-derived polioviruses: current state of knowledge. Bull WHO 2004, 82:16-23. 2585883, 15106296.
36. Kew OM, Mulders MN, Lipskaya GY, da Silva EE, Pallansch MA. Molecular epidemiology of polioviruses. Semin Virol 1995, 6:401-414.
37. Dabis F, Ekpini E. HIV-1/AIDS and maternal and child health in Africa. Lancet 2002, 359:2097-2104. 10.1016/S0140-6736(02)08909-2, 12086778.